What is Qosina?
Founded in 1980 and headquartered in Ronkonkoma, NY, Qosina operates as a key supplier of original equipment manufacturer (OEM) components. The company specializes in hemostasis valves, various components, features, and materials crucial for cardiology and vascular access applications. Its long-standing presence in the industry highlights a deep understanding of the medical device sector's stringent requirements and a commitment to providing essential parts for critical healthcare solutions.
How much funding has Qosina raised?
Qosina has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Qosina
PPP
Public-Private Partnership
What's next for Qosina?
With this substantial enterprise-level backing, Qosina is poised for accelerated expansion. The strategic investment is likely to fuel advancements in product development, enhance manufacturing capabilities, and broaden its distribution network. Future initiatives may include exploring new market segments within medical devices or strengthening its existing portfolio of cardiology and vascular access components. The company's focus will likely remain on maintaining its reputation for quality and reliability while capitalizing on new opportunities for growth and innovation in the healthcare supply chain.
See full Qosina company page
